A Phase 3 Study of First-Line Sotorasib, Panitumumab, and FOLFIRI Versus FOLFIRI with or Without Bevacizumab-Awwb for Patients with KRAS G12C–mutated Metastatic Colorectal Cancer (codebreak 301).
Journal of Clinical Oncology（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要